| AESTHER-HEALTHCARE-ACQUISITION-CORP |
AESTHER-HEALTHCARE-ACQUISITION-CORP |
62%
|
such additional Notes at (a) fair value under the fair value option or (b) an amortized cost. Refer to Note 7, Senior Secured Convertible Notes, for further detail on the terms of the Notes and poten… |
| AESTHER-HEALTHCARE-SPONSOR-LLC |
AESTHER-HEALTHCARE-SPONSOR-LLC |
62%
|
such additional Notes at (a) fair value under the fair value option or (b) an amortized cost. Refer to Note 7, Senior Secured Convertible Notes, for further detail on the terms of the Notes and poten… |
| AHAC-AESTHER-HEALTHCARE-SPONSOR-LLC |
AHAC-AESTHER-HEALTHCARE-SPONSOR-LLC |
62%
|
n December 5, 2022 (the “Business Combination Agreement”), by and among, AHAC, AHAC Merger Sub Inc., a wholly-owned subsidiary of AHAC, Aesther Healthcare Sponsor, LLC, Legacy Ocean, and Dr. Chirinje… |
| AHAC-AHAC-MERGER-SUB-INC |
AHAC-AHAC-MERGER-SUB-INC |
62%
|
n December 5, 2022 (the “Business Combination Agreement”), by and among, AHAC, AHAC Merger Sub Inc., a wholly-owned subsidiary of AHAC, Aesther Healthcare Sponsor, LLC, Legacy Ocean, and Dr. Chirinje… |
| CAPITAL-RESOURCES |
CAPITAL-RESOURCES |
62%
|
inistrative expense for the three months ended March 31, 2025 increased by $0.4 million, as compared to the three months ended March 31, 2024. The $0.4 million increase was primarily driven by increa… |
| EMERGING-GROWTH-COMPANY |
EMERGING-GROWTH-COMPANY |
62%
|
such additional Notes at (a) fair value under the fair value option or (b) an amortized cost. Refer to Note 7, Senior Secured Convertible Notes, for further detail on the terms of the Notes and poten… |
| LONZA-AG |
LONZA-AG |
62%
|
he Company calls the IPO Warrants for redemption as described above, its management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such … |
| NASDAQ-STOCK-MARKET-LLC |
NASDAQ-STOCK-MARKET-LLC |
62%
|
and other fees, which Legacy Ocean stockholders received in the form of shares of common stock of the Company (the consummation of the business combination and other transactions contemplated by the … |
| OCEAN-BIOMEDICAL-HOLDINGS-INC |
OCEAN-BIOMEDICAL-HOLDINGS-INC |
62%
|
$ 2,048 Non-cash stock issuances $ 10,657 $ - Common stock issued in consideration for extension of loans $ - $ 13,953 See accompanying notes to the unaudited condensed consolidated financial stateme… |
| OCEAN-CHITOFIBRORX-INC |
OCEAN-CHITOFIBRORX-INC |
62%
|
ent”). Upon closing this agreement, AHAC changed its name from “Aesther Healthcare Acquisition Corp.” to “Ocean Biomedical, Inc.” and is referred to herein as “the Company.” Unless context otherwise … |
| OCEAN-CHITORX-INC |
OCEAN-CHITORX-INC |
62%
|
ent”). Upon closing this agreement, AHAC changed its name from “Aesther Healthcare Acquisition Corp.” to “Ocean Biomedical, Inc.” and is referred to herein as “the Company.” Unless context otherwise … |
| OCEAN-PROMISE-INC |
OCEAN-PROMISE-INC |
62%
|
ent”). Upon closing this agreement, AHAC changed its name from “Aesther Healthcare Acquisition Corp.” to “Ocean Biomedical, Inc.” and is referred to herein as “the Company.” Unless context otherwise … |
| OCEAN-SIHOMA-INC |
OCEAN-SIHOMA-INC |
62%
|
ent”). Upon closing this agreement, AHAC changed its name from “Aesther Healthcare Acquisition Corp.” to “Ocean Biomedical, Inc.” and is referred to herein as “the Company.” Unless context otherwise … |
| SECOND-STREET-CAPITAL-LLC |
SECOND-STREET-CAPITAL-LLC |
62%
|
such additional Notes at (a) fair value under the fair value option or (b) an amortized cost. Refer to Note 7, Senior Secured Convertible Notes, for further detail on the terms of the Notes and poten… |
| UPON-CLOSING-AHAC-MERGER-SUB-INC |
UPON-CLOSING-AHAC-MERGER-SUB-INC |
62%
|
n December 5, 2022 (the “Business Combination Agreement”), by and among, AHAC, AHAC Merger Sub Inc., a wholly-owned subsidiary of AHAC, Aesther Healthcare Sponsor, LLC, Legacy Ocean, and Dr. Chirinje… |
| VELLAR-OPPORTUNITY-FUND-SPV-LLC |
VELLAR-OPPORTUNITY-FUND-SPV-LLC |
62%
|
director or officer, disputes could arise between us and our subsidiary’s partners regarding a conflict of interest. These partners also may disagree with the amount and quality of resources that our… |
| WHITE-LION-CAPITAL-LLC |
WHITE-LION-CAPITAL-LLC |
62%
|
director or officer, disputes could arise between us and our subsidiary’s partners regarding a conflict of interest. These partners also may disagree with the amount and quality of resources that our… |
